Home

David Lamond, Director: Quince Therapeutics QNCX Buy · Filed 23/12/01

Trade details

Type
Insider buy
Amount
$14,090.44
Shares · price
14,378 sh · $0.98 a share
Held after
2,193,539 sh
Trade date
23/11/29
Filed
23/12/01
Days to filing
2 days

Holdings up 0.7%

Insiders buying this week
1 insiders
Holding change
+0.7%

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 23/10/30~23/12/29

David Lamond's recent trades

  • David Lamond

    BuyQuince Therapeutics

    $23.5K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.8K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $22.6K

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $300

    Filed 23/12/14

  • David Lamond

    BuyQuince Therapeutics

    $19.5K

    Filed 23/12/07

David Lamond, Director — bought $14.1K of Quince Therapeutics QNCX · 14,378 sh @ $0.98 | Whalegun